To determine whether endoscopic laser treatment improves both ventilation and perfusion in patients with advanced lung cancer, krypton-81m ventilation and technetium-99m labelled macroaggregate perfusion scanning was performed immediately before and two or four days after treatment in a consecutive series of 28 patients. Twelve patients had not received any other treatment before laser therapy and 16 had undergone previous treatments that included radiotherapy. Ventilation and perfusion were quantified by expressing the number of counts in the affected lung as a percentage of the total counts. Ventilation and perfusion improved after laser treatment in 23 patients (82%). The mean ventilation score in the affected lung rose by 50% (p < 0001) and the mean perfusion score rose by 24% (p < 0@001). Incremental changes in ventilation and perfusion scores were positively correlated (r = 0@80). Mean spirometric values, six minute walking distance, the Karnofsky performance index, and breathlessness and wellbeing scores also improved significantly. Patients with main bronchial obstruction who had had no radiotherapy showed the most striking improvements. It is concluded that the removal of intraluminal tumour from the bronchial tree leads to matched improvements in ventilation and perfusion in most patients and that this is associated with valuable improvement in symptoms.
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During the last eight years treatment with the neodymium YAG laser has become established as an important palliative treatment in patients with advanced lung cancer. ' treatment is important. It is well known that perfusion to a lung affected by bronchogenic carcinoma may be considerably impaired6 and there is evidence in some patients to suggest that this is caused by tumour compressing or distorting the pulmonary vessels.7 Removal of the intraluminal component of a tumour from the airway might therefore improve ventilation but have no effect on perfusion, with the result that laser treatment might merely increase the physiological dead space within the lung.
We have examined changes in ventilation and perfusion produced by laser treatment of obstructing tumours by performing radionuclide lung scanning before and after treatment in a series of 28 consecutive patients.
Methods

PATIENTS
Patients with inoperable tumours were assessed initially by fibreoptic bronchoscopy. They were judged to be suitable for laser treatment if the airway was obstructed by predominantly intraluminal tumour, and they were recruited into the study if the tumour was causing unilateral obstruction within the bronchial tree.
We studied 28 patients (17 (20) months in the radiotherapy group and 4 (7) months in the untreated group; this difference was significant (p < 0 05, unpaired t test).
LASER TREATMENT
All patients were treated with a neodymium YAG laser (Fiberlase 100, Pilkington Medical Systems) under general anaesthesia, a combination of flexible and rigid bronchoscopes being used. Full details of this method have been described.8 All treatments were performed by the same bronchoscopist (PJMG).
RADIONUCLIDE LUNG SCANS
Ventilation was assessed by the use of krypton-81m gas and perfusion with human albumin macroaggregates labelled with technetium-99m.9 Scanning was performed immediately before and either two or four days after laser treatment, depending on the availability of the parent isotope, rubidium-81. Anterior and posterior views were obtained and the number of counts in each lung was averaged by taking the geometric mean from these two views. The geometric mean was used in preference to the arithmetic mean as it provides a correction for depth and therefore gives a more accurate estimate of whole lung counts.
Ventilation and perfusion were quantified by expressing the mean number of counts in the treated lung as a percentage of the sum of the counts from both lungs to produce a fractional score as follows: Fractional score = mean counts from treated lung x 100. Data were acquired by the use of a dedicated computer during imaging and were analysed to produce subtraction images derived from scans before and after treatment. The purpose of the computer subtraction was to show the areas of change in the treated lung; an example is shown in figure 1.
ASSESSMENTS OF THE CLINICAL RESPONSE TO TREATMENT
All patients were assessed immediately before and either two or four days after laser treatment (on the same day as the radionuclide lung scanning Before Afier n were marked "very, very breathless" and "not at all breathless" for breathlessness, and "very, very ill" and "very, very well" for wellbeing. The patients indicated with a mark where their present state fell between these two extremes, the worst possible score being 0 mm and the best possible score being 100 mm. In addition, breathlessness was quantified by using the MRC questionnaire. 
Results
RADIONUCLIDE LUNG SCANS
Ventilation and perfusion scores improved in 23 patients (82%). In all cases computer subtractions confirmed that the greatest improvements in ventilation and perfusion were in the treated areas. The mean ventilation score rose from 23x8 to 35-8 (p < 0-001), and the mean perfusion score rose from 24-6 to 30 6 (p < 0-001).
Patients with tumours causing obstruction in main bronchi generally had the lowest ventilation and perfusion scores before treatment, but showed the greatest improvements after treatment (fig 2) : the mean fractional ventilation score rose from 17-4 to 32-1 (p < 0-001) and the mean fractional perfusion score rose from 19 1 to 27-0 (p < 0 001). Changes in ventilation and perfusion scores were not significant in the seven patients with obstruction of intermediate and lobar bronchi; individual patients within this group, however, undoubtedly improved (see example in fig 1) .
The possible effect of previous radiotherapy on the response to laser treatment was examined by comparing the results obtained in patients who had and had not received radiotherapy. In patients with main bronchial obstruction the nine patients who had not undergone previous treatment tended to show greater improvements in ventilation and perfusion scores than the 12 patients who had received previous radiotherapy (fig 3) . This difference was significant when the mean incremental changes in the two groups were compared (p = 0-02 for ventilation and 0 04 for perfusion, unpaired t test). In patients with obstruction of intermediate and lobar bronchi no differences were found between the radiotherapy and untreated groups. Samples of arterial blood were obtained before and after laser treatment in 15 patients with main bronchial obstruction. The results were not examined for the possible effects of radiotherapy because of the small numbers. The mean (SD) arterial oxygen tension rose from 10-1 (2 0) to 11 1 (1 8) kPa; this increase did not, however, quite attain significance (p = 0 1). There was no change in the mean pretreatment and post-treatment carbon dioxide tensions (4 1 (I 1) and 4 2 (0 5) kPa). Discussion 8lMKr ventilation and 99mT perfusion scans provide an image of the relative distribution of ventilation and perfusion in the lung during physiological tidal breathing.9 Although the technique cannot provide absolute measurements of ventilation and perfusion, serial scans are thought to provide a reliable index of change."4 Our results thus provide evidence that laser treatment leads to improved ventilation and perfusion in the affected lung in patients with obstruction of the main bronchus. The effect of treatment in patients with more peripheral obstruction is more difficult to assess in view of the small number of patients studied; although significant improvements were not seen in the whole group, individual patients undoubtedly improved (fig 1) .
Although ventilation scores tended to im- prove more than perfusion scores, incremental changes in individual patients were positively correlated (fig 4) . This suggests that laser treatment should lead to an overall improvement in gas exchange rather than merely increase the physiological dead space within the lung. The changes in arterial blood gases observed after treatment in patients with main bronchial obstruction, though not attaining statistical significance, suggest a reduction in the proportion of lung units with unfavourable ventilation: perfusion ratios. The results obtained with radionuclide lung scans were consistent with independently obtained assessments. The groups showing the most striking improvements in lung function (table 1) and performance and symptom scores (table 2) also showed the most striking improvements in ventilation and perfusion. Symptomatic and clinical improvement thus appears to reflect a genuine physiological gain rather than a simple placebo effect of the laser.
Gilmartin et al'5 have recently reported changes in perfusion in patients undergoing treatment with a carbon dioxide laser. Improvements in perfusion were noted in seven out of 13 patients 10 days after treatment; the changes were relatively modest, however, and not significant. The patients in that study and the method of assessing perfusion were similar to ours; but the carbon dioxide laser may represent an important difference. The beam of this laser cannot be transmitted in a conventional optical fibre and so a rigid delivery system must be used. Access to peripherally situated tumours may therefore not be as good as with the neodymium YAG laser, with the result that the airway may not be so thoroughly cleared.
In the study by Gilmartin et al'5 indices of lung function and breathlessness tended to improve between the first and the tenth postoperative day. Resolution of exudate and oedema at the site of treatment and recovery from the anaesthetic were thought to account for this gradual improvement. In the present cudy postoperative assessments were performed on either the second or the fourth day, when these effects may still be operating. Possibly therefore our results have underestimated the improvement that was obtained with the neodymium YAG laser. Significant improvements in ventilation and perfusion have been observed in patients undergoing radiotherapy.'4 The nature of the response was similar to that reported here; the action of radiotherapy on the lung, however, is likely to differ from that of the laser. The improvements in ventilation and perfusion obtained with radiotherapy were thought to result from shrinkage of the tumour, with consequent relief of infiltration or compression of airways and blood vessels, or both.'4 Laser treatment, on the other hand, probably has little effect on the mechanical compression of blood vessels.
How then does laser treatment improve lung perfusion? It is well known that alveolar hypoxia leads to reflex regional pulmonary vasoconstriction." Studies in dogs have shown that obstruction of the bronchial tree with balloon catheters leads to large perfusion defects, and it has been suggested that endobronchial tumours produce similar effects
